The evaluation of right and left ventricular dysfunction in COPD patients with pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 250s Year: 2001
Right ventricular dysfunction in patients with pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 335s Year: 2005
Pulmonary hypertension, right and left ventricular dysfunction in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 404s Year: 2006
Pulmonary hypertension and right ventricular impairment in patients with sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011
Prognostic value of right ventricular dilatation in patients with low-risk pulmonary embolism Source: Eur Respir J, 50 (6) 1701611; 10.1183/13993003.01611-2017 Year: 2017
Pulmonary hypertension and right ventricular impairment in patients with interstitial pneumonia Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011
In patients with intermediate-low risk pulmonary embolism: cardiac enzyme or right ventricle dysfunction or sPESI Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017
Prognostic value of right ventricular dilatation in patients with low risk pulmonary embolism Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017
Pulmonary hypertension and right ventricular impairment in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 59s Year: 2004
Macitentan in pulmonary hypertension due to left ventricular dysfunction Source: Eur Respir J, 51 (2) 1701886; 10.1183/13993003.01886-2017 Year: 2018
Evaluation of right atrium remodeling in patients with COPD complicated by pulmonary artery hypertension Source: Annual Congress 2010 - State of the art imaging Year: 2010
Myocarditis of the right and left ventricle following acute pulmonary embolism Source: Eur Respir J 2007; 30: Suppl. 51, 487s Year: 2007
Left ventricular diastolic dysfunction in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010
CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension Source: Eur Respir J, 57 (4) 1901192; 10.1183/13993003.01192-2019 Year: 2021
Right ventricular stiffness impairs right atrial function in pulmonary arterial hypertension Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension Year: 2020
Right ventricular dysfunction and functional limitation in idiopathic pulmonary fibrosis Source: Eur Respir J 2008; 31: 219-220 Year: 2008
Right ventricular diastolic dysfunction of as an early sign of cardiac involvement in pulmonary sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 279s Year: 2004
Prevalence of pulmonary hypertension and right ventricular dysfunction in patients with mixed types of ILD Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011
Right ventricular reserve in a piglet model of chronic pulmonary hypertension Source: Eur Respir J 2015; 45: 709-717 Year: 2015
Can pulmonary arterial CT obstruction index rate predict right ventricular dilatation in pulmonary embolism? Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots Year: 2015